Zhu Changbin, Mustafa Dana, Zheng Ping-Pin, van der Weiden Marcel, Sacchetti Andrea, Brandt Maarten, Chrifi Ihsan, Tempel Dennie, Leenen Pieter J M, Duncker Dirk Jan, Cheng Caroline, Kros Johan M
Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands.
Department of Pediatric Neurosurgery, Shanghai Xinhua Hospital affiliated to School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Neuro Oncol. 2017 May 1;19(5):648-659. doi: 10.1093/neuonc/now251.
The majority of glioma-associated microglia/macrophages have been identified as M2-type macrophages with immune suppressive and tumor supportive action. Recently, the extracellular adenosine deaminase protein Cat Eye Syndrome Critical Region Protein 1 (CECR1) was shown to regulate macrophage maturation. In this study, we investigate the role of CECR1 in the regulation of the glioma-associated macrophage response.
Expression of CECR1 was assessed in human glioma samples. CECR1-mediated macrophage response was studied in vitro, using donor derived CD14+ monocytes and the THP-1 monocytic cell line. The response of the human glioma cell line U87 to conditioned medium of macrophages preconditioned with recombinant human CECR1 or CECR1 silencing was also assessed.
CECR1 was strongly expressed in high-grade gliomas (P < .001) and correlated positively with the M2 phenotype markers in tumor-associated microglia/macrophages (TAMs) (overall, P < .05). In vitro studies confirmed the presence of a significantly higher level of CECR1 expression in M2-like macrophages exposed to U87 conditioned medium (P < .001). CECR1 knockdown or stimulation of macrophages affected differentiation toward the M2-like phenotype. Stimulation of U87 cells with conditioned medium of CECR1 knockdown or stimulated macrophages affected tumor cell proliferation and migration, coinciding with altered intracellular signaling of mitogen-activated protein kinase (MAPK). In glioma tissue samples, CECR1 expression correlated with Ki67 and MAPK signaling protein.
CECR1 is a potent regulator of TAM polarization and is consistently highly expressed by M2-type TAMs, particularly in high-grade glioma. Paracrine effects induced by CECR1 in M2-like TAMs activate MAPK signaling and stimulate the proliferation and migration of glioma cells.
大多数胶质瘤相关的小胶质细胞/巨噬细胞已被鉴定为具有免疫抑制和肿瘤支持作用的M2型巨噬细胞。最近,细胞外腺苷脱氨酶蛋白猫眼综合征关键区域蛋白1(CECR1)被证明可调节巨噬细胞成熟。在本研究中,我们调查CECR1在调节胶质瘤相关巨噬细胞反应中的作用。
评估人胶质瘤样本中CECR1的表达。使用供体来源的CD14+单核细胞和THP-1单核细胞系在体外研究CECR1介导的巨噬细胞反应。还评估了人胶质瘤细胞系U87对用重组人CECR1预处理或CECR1沉默的巨噬细胞条件培养基的反应。
CECR1在高级别胶质瘤中强烈表达(P <.001),并与肿瘤相关小胶质细胞/巨噬细胞(TAM)中的M2表型标志物呈正相关(总体,P <.05)。体外研究证实,暴露于U87条件培养基的M2样巨噬细胞中CECR1表达水平显著更高(P <.001)。CECR1基因敲低或巨噬细胞刺激影响向M2样表型的分化。用CECR1基因敲低或刺激的巨噬细胞条件培养基刺激U87细胞影响肿瘤细胞增殖和迁移,这与丝裂原活化蛋白激酶(MAPK)的细胞内信号改变一致。在胶质瘤组织样本中,CECR1表达与Ki67和MAPK信号蛋白相关。
CECR1是TAM极化的有效调节因子,并且始终由M2型TAM高度表达,特别是在高级别胶质瘤中。CECR1在M2样TAM中诱导的旁分泌作用激活MAPK信号并刺激胶质瘤细胞的增殖和迁移。